LRRK2 and Parkinson disease: The involvement of mitochondria in PD is further supported by: (1) PD-linked mitochondrial targeted toxins (MPTP, rotenone); (2) mutations in mitochondrial-related genes (PARK2, LRRK2, PINK1); and (3) mitochondrial dysfunction in PD patient brains [30–35].